Proposal to end sell-through period for unlicensed herbal medicines
Download the full outcome
Detail of outcome
Following a public consultation on proposals to end the ‘sell through’ of unlicensed herbal remedies legally on the market in April 2011, the MHRA has decided that with effect from 1 May 2014, all herbal medicinal products sold in the UK that fall under Directive 2004/24/EC require either a full marketing authorisation (MA) or a traditional herbal registration (THR) in order to remain on the market.
Original consultation
Consultation description
The MHRA is undertaking a public consultation on proposals to end the ‘sell through’ of unlicensed herbal remedies legally on market at April 2011.
In April 2011, a transition period under the Traditional Herbal Medicinal Products Directive came to an end, meaning that all herbal medicines had to be licensed under the Traditional Herbal Registration Scheme if they were to continue to be sold as such. But before the end of the transition period, the MHRA said it would allow stocks of products that were already legally on the market in retail before 30 April 2011 to be sold through.
The MHRA is now proposing that this sell-through period come to an end on 31 December 2013.
